sulpiride and Idiopathic Parkinson Disease studies

sulpiride and Idiopathic Parkinson Disease

Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.

Research Excerpts

Excerpt	Relevance	Reference
"Levosulpiride is a substituted benzamide that is widely used for the management of dyspepsia and emesis."	5.35	Levosulpiride-induced movement disorders. ( Chung, SJ; Kim, JS; Kim, MJ; Lee, MC; Shin, HW, 2009)
"Levosulpiride is a substituted benzamide that is widely used for the management of dyspepsia and emesis."	1.35	Levosulpiride-induced movement disorders. ( Chung, SJ; Kim, JS; Kim, MJ; Lee, MC; Shin, HW, 2009)
" Adverse effects were acute dyskinesia (n=2) or parkinsonian syndrome, which occurred after several months or years of treatment (n=15)."	1.33	[Extrapyramidal adverse effects of veralipride (Agreal), a drug used to treat hot flushes: a propos of 17 cases]. ( Andréjak, M; Geslin, JM; Gras-Champel, V; Lemaire-Hurtel, AS; Masmoudi, K; Masson, H; Munier, A, 2005)
"Levodopa-induced dyskinesias (LID) in Parkinson's disease (PD) may be classified into three main categories: "On" dyskinesias, diphasic dyskinesias (DD), and "off" periods."	1.28	Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification. ( Gershanik, O; Luquin, MR; Obeso, JA; Scipioni, O; Vaamonde, J, 1992)
"The neuroleptic-induced catalepsy was reversed by the classical anti-parkinsonian agent L-DOPA and by agents that function through dopamine systems such as d- and methamphetamine and the direct D2 receptor agonist quinpirole."	1.28	Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents. ( Close, SP; Elliott, PJ; Hayes, AG; Marriott, AS; Walsh, DM, 1990)

Research

Studies (34)

Timeframe	Studies, this research(%)	All Research%
pre-1990	9 (26.47)	18.7374
1990's	14 (41.18)	18.2507
2000's	7 (20.59)	29.6817
2010's	3 (8.82)	24.3611
2020's	1 (2.94)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

9 (26.47)

18.7374

1990's

14 (41.18)

18.2507

2000's

7 (20.59)

29.6817

2010's

3 (8.82)

24.3611

2020's

1 (2.94)

2.80

Authors

Authors	Studies
Zarrindast, MR	1
Fazli-Tabaei, S	1
Khakpai, F	1
Cáceres-Chávez, VA	1
Hernández-Martínez, R	1
Pérez-Ortega, J	1
Herrera-Valdez, MA	1
Aceves, JJ	1
Galarraga, E	1
Bargas, J	1
Naguy, A	1
AlHumoud, A	1
Stopper, H	1
Schupp, N	1
Fazeli, G	1
Dietel, B	1
Queisser, N	1
Walitza, S	1
Gerlach, M	1
Shin, HW	1
Kim, MJ	1
Kim, JS	1
Lee, MC	1
Chung, SJ	1
Martí Massó, JF	1
Ruiz-Martínez, J	1
Bergareche, A	1
López de Munain, A	1
Ohye, C	1
Shibazaki, T	1
Kovoor, A	1
Seyffarth, P	1
Ebert, J	1
Barghshoon, S	1
Chen, CK	1
Schwarz, S	1
Axelrod, JD	1
Cheyette, BN	1
Simon, MI	1
Lester, HA	1
Schwarz, J	1
Masmoudi, K	1
Gras-Champel, V	1
Lemaire-Hurtel, AS	1
Masson, H	1
Munier, A	1
Geslin, JM	1
Andréjak, M	1
Brusa, L	1
Petta, F	1
Pisani, A	1
Miano, R	1
Stanzione, P	4
Moschella, V	1
Galati, S	1
Finazzi Agrò, E	1
Campbell, DJ	1
Mendelsohn, FA	1
Adam, WR	1
Funder, JW	1
Pierantozzi, M	3
Semprini, R	3
Tagliati, M	3
Traversa, R	2
Peppe, A	2
Pierelli, F	1
Bernardi, G	4
Liptrot, J	1
Holdup, D	1
Phillipson, O	1
Strange, PG	1
Yanagisawa, N	1
Bodis-Wollner, I	3
Sarre, S	1
Ebinger, G	1
Michotte, Y	1
Mercuri, NB	1
Federici, M	1
Teive, HA	1
Sa, DS	1
Lees, AJ	1
Lander, CM	1
Stern, GM	1
Leger, JM	1
Dumond, JJ	1
Garoux, R	1
Lombertie, E	1
Dumas, M	1
Graux, P	1
Durocher, AM	1
Corsini, GU	1
Zompo, MD	1
Cianchetti, C	1
Mangoni, A	1
Luquin, MR	1
Scipioni, O	1
Vaamonde, J	1
Gershanik, O	1
Obeso, JA	1
Marciani, MG	1
Lawrence, MS	1
Redmond, DE	1
Elliott, PJ	2
Close, SP	2
Walsh, DM	2
Hayes, AG	2
Marriott, AS	2
Gershanik, OS	1
Rubinstein, M	1
Stefano, F	1
Joshita, Y	1
Yamamoto, K	1
Noda, S	1
Umezaki, H	1
Koller, W	1
Herbster, G	1
Anderson, D	1
Wack, R	1
Gordon, J	1

Studies

Zarrindast, MR

Fazli-Tabaei, S

Khakpai, F

Cáceres-Chávez, VA

Hernández-Martínez, R

Pérez-Ortega, J

Herrera-Valdez, MA

Aceves, JJ

Galarraga, E

Bargas, J

Naguy, A

AlHumoud, A

Stopper, H

Schupp, N

Fazeli, G

Dietel, B

Queisser, N

Walitza, S

Gerlach, M

Shin, HW

Kim, MJ

Kim, JS

Lee, MC

Chung, SJ

Martí Massó, JF

Ruiz-Martínez, J

Bergareche, A

López de Munain, A

Ohye, C

Shibazaki, T

Kovoor, A

Seyffarth, P

Ebert, J

Barghshoon, S

Chen, CK

Schwarz, S

Axelrod, JD

Cheyette, BN

Simon, MI

Lester, HA

Schwarz, J

Masmoudi, K

Gras-Champel, V

Lemaire-Hurtel, AS

Masson, H

Munier, A

Geslin, JM

Andréjak, M

Brusa, L

Petta, F

Pisani, A

Miano, R

Stanzione, P

Moschella, V

Galati, S

Finazzi Agrò, E

Campbell, DJ

Mendelsohn, FA

Adam, WR

Funder, JW

Pierantozzi, M

Semprini, R

Tagliati, M

Traversa, R

Peppe, A

Pierelli, F

Bernardi, G

Liptrot, J

Holdup, D

Phillipson, O

Strange, PG

Yanagisawa, N

Bodis-Wollner, I

Sarre, S

Ebinger, G

Michotte, Y

Mercuri, NB

Federici, M

Teive, HA

Sa, DS

Lees, AJ

Lander, CM

Stern, GM

Leger, JM

Dumond, JJ

Garoux, R

Lombertie, E

Dumas, M

Graux, P

Durocher, AM

Corsini, GU

Zompo, MD

Cianchetti, C

Mangoni, A

Luquin, MR

Scipioni, O

Vaamonde, J

Gershanik, O

Obeso, JA

Marciani, MG

Lawrence, MS

Redmond, DE

Elliott, PJ

Close, SP

Walsh, DM

Hayes, AG

Marriott, AS

Gershanik, OS

Rubinstein, M

Stefano, F

Joshita, Y

Yamamoto, K

Noda, S

Umezaki, H

Koller, W

Herbster, G

Anderson, D

Wack, R

Gordon, J

Reviews

4 reviews available for sulpiride and Idiopathic Parkinson Disease

Article	Year
Is aldosterone secretion under dopaminergic control? Circulation research, 1981, Volume: 49, Issue:6 Topics: Aldosterone; Bromocriptine; Chlorpromazine; Dopamine; Dopamine Antagonists; Edema; Humans; Levodopa;	1981
Dopamine receptors in the basal ganglia: relevance to Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:3 Topics: Basal Ganglia; Basal Ganglia Diseases; Brain; Clozapine; Dopamine Agents; Dopamine D2 Receptor Antag	1993
Electrophysiological assessment of retinal dopaminergic deficiency. Electroencephalography and clinical neurophysiology. Supplement, 1996, Volume: 46 Topics: Animals; Aphakia; Dopamine; Dopamine Antagonists; Electrodiagnosis; Electroretinography; Evoked Pote	1996
[Psychiatric manifestations induced by dopamine precursors or antagonists]. Annales medico-psychologiques, 1979, Volume: 137, Issue:9 Topics: Anxiety; Bromocriptine; Confusion; Dopamine Antagonists; Dreams; Female; Hallucinations; Humans; Lev	1979

Article

Year

Is aldosterone secretion under dopaminergic control?

Circulation research, 1981, Volume: 49, Issue:6

Topics: Aldosterone; Bromocriptine; Chlorpromazine; Dopamine; Dopamine Antagonists; Edema; Humans; Levodopa;

1981

Dopamine receptors in the basal ganglia: relevance to Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:3

Topics: Basal Ganglia; Basal Ganglia Diseases; Brain; Clozapine; Dopamine Agents; Dopamine D2 Receptor Antag

1993

Electrophysiological assessment of retinal dopaminergic deficiency.

Electroencephalography and clinical neurophysiology. Supplement, 1996, Volume: 46

Topics: Animals; Aphakia; Dopamine; Dopamine Antagonists; Electrodiagnosis; Electroretinography; Evoked Pote

1996

[Psychiatric manifestations induced by dopamine precursors or antagonists].

Annales medico-psychologiques, 1979, Volume: 137, Issue:9

Topics: Anxiety; Bromocriptine; Confusion; Dopamine Antagonists; Dreams; Female; Hallucinations; Humans; Lev

1979

Other Studies

30 other studies available for sulpiride and Idiopathic Parkinson Disease

Article	Year
Synergistic effect between quinpirole and L-NAME as well as sulpiride and L-arginine on the modulation of anxiety and memory processes in the 6-OHDA mouse model of Parkinson's disease: An isobologram analysis. Neurobiology of learning and memory, 2021, Volume: 186 Topics: Adrenergic Agents; Animals; Anxiety; Arginine; Disease Models, Animal; Dopamine Agonists; Dopamine A	2021
Acute dopamine receptor blockade in substantia nigra pars reticulata: a possible model for drug-induced Parkinsonism. Journal of neurophysiology, 2018, 12-01, Volume: 120, Issue:6 Topics: Action Potentials; Animals; Benzazepines; Disease Models, Animal; Dopamine Antagonists; Dopaminergic	2018
An octogenarian with Parkinson's disease psychosis that has responded favourably to low-dose sulpiride with facilitated motoric agility. Asian journal of psychiatry, 2019, Volume: 43 Topics: Aged, 80 and over; Antipsychotic Agents; Humans; Male; Parkinson Disease; Psychotic Disorders; Sulpi	2019
Genotoxicity of the neurotransmitter dopamine in vitro. Toxicology in vitro : an international journal published in association with BIBRA, 2009, Volume: 23, Issue:4 Topics: Animals; Antioxidants; Apoptosis; Cells, Cultured; Dopamine; Humans; Micronucleus Tests; Mutagenicit	2009
Levosulpiride-induced movement disorders. Movement disorders : official journal of the Movement Disorder Society, 2009, Nov-15, Volume: 24, Issue:15 Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Brain; Female; Humans; Magnetic Resonance Imag	2009
[Parkinsonism induced by sulpiride and veralipride: two different stories]. Medicina clinica, 2011, Oct-15, Volume: 137, Issue:10 Topics: Adult; Aged; Brain Damage, Chronic; Contraindications; Dyskinesia, Drug-Induced; Europe; Female; Hum	2011
Lesioning the thalamus for dyskinesia. Stereotactic and functional neurosurgery, 2001, Volume: 77, Issue:1-4 Topics: Antiparkinson Agents; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dyskinesias; Electrocoagulatio	2001
D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005, Feb-23, Volume: 25, Issue:8 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Antipsych	2005
[Extrapyramidal adverse effects of veralipride (Agreal), a drug used to treat hot flushes: a propos of 17 cases]. La Revue de medecine interne, 2005, Volume: 26, Issue:6 Topics: Aged; Akathisia, Drug-Induced; Basal Ganglia Diseases; Dopamine Antagonists; Female; Humans; Male; M	2005
Central acute D2 stimulation worsens bladder function in patients with mild Parkinson's disease. The Journal of urology, 2006, Volume: 175, Issue:1 Topics: Domperidone; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Severity of	2006
Increasing doses of l-sulpiride reveal dose- and spatial frequency-dependent effects of D2 selective blockade in the human electroretinogram. Vision research, 1995, Volume: 35, Issue:18 Topics: Adult; Dose-Response Relationship, Drug; Electroretinography; Female; Humans; Male; Parkinson Diseas	1995
1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol inhibits tyrosine hydroxylase activity in rat striatal synaptosomes. Journal of neural transmission. General section, 1994, Volume: 96, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biopterins; Chromatography, High Pressure Liq	1994
[Diagnosis and treatment of Parkinson's disease in the elderly]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1993, Volume: 30, Issue:12 Topics: Aged; Brain; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sulpirid	1993
The visual system in Parkinson's disease. Advances in neurology, 1993, Volume: 60 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Contrast Sensitivity; Dopamine; Electroenceph	1993
Levodopa biotransformation in hemi-Parkinson rats: effect of dopamine receptor agonists and antagonists. European journal of pharmacology, 1996, Feb-05, Volume: 296, Issue:3 Topics: Animals; Antiparkinson Agents; Benzazepines; Biotransformation; Corpus Striatum; Denervation; Dopami	1996
A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's disease pattern electroretinogram alterations. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 1999, Volume: 110, Issue:1 Topics: Adult; Brain; Electroencephalography; Electroretinography; Haloperidol; Humans; Parkinson Disease; R	1999
Inhibition of catechol-O-methyltransferase (COMT) in the brain does not affect the action of dopamine and levodopa: an in vitro electrophysiological evidence from rat mesencephalic dopamine neurons. Journal of neural transmission (Vienna, Austria : 1996), 1999, Volume: 106, Issue:11-12 Topics: Animals; Benzophenones; Catechol O-Methyltransferase Inhibitors; Cells, Cultured; Dopamine; Dopamine	1999
Worsening of Parkinsonism after the use of veralipride for treatment of menopause: case report. Arquivos de neuro-psiquiatria, 2001, Volume: 59, Issue:1 Topics: Dopamine Antagonists; Female; Humans; Menopause; Middle Aged; Parkinson Disease; Parkinson Disease,	2001
Tiapride and sulpiride in Parkinson's disease. Lancet (London, England), 1978, Dec-02, Volume: 2, Issue:8101 Topics: Benzamides; Drug Evaluation; Dyskinesia, Drug-Induced; Humans; Parkinson Disease; Sulpiride	1978
[Value of sulpiride and tiapride in geriatrics. Antagonism between Parkinson disease and chorea]. Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille, 1979, Nov-17, Volume: Suppl 1 Topics: Aged; Benzamides; Chorea; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Sulpiride;	1979
Therapeutical efficacy of a combination of apomorphine with sulpiride or metoclopramide in Parkinsonism. Psychopharmacologia, 1976, May-28, Volume: 47, Issue:2 Topics: Adult; Apomorphine; Drug Therapy, Combination; Haloperidol; Humans; Male; Metoclopramide; Parkinson	1976
Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification. Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:2 Topics: Aged; Apomorphine; Chlorpromazine; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Dr	1992
An electrophysiological study of D2 dopaminergic actions in normal human retina: a tool in Parkinson's disease. Neuroscience letters, 1992, Jun-08, Volume: 140, Issue:1 Topics: Adult; Dopamine D2 Receptor Antagonists; Humans; Parkinson Disease; Receptors, Dopamine D2; Referenc	1992
MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys. Pharmacology, biochemistry, and behavior, 1991, Volume: 38, Issue:4 Topics: Animals; Apomorphine; Blinking; Chlorocebus aethiops; Dopamine Agents; Haloperidol; Male; MPTP Poiso	1991
Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents. Journal of neural transmission. Parkinson's disease and dementia section, 1990, Volume: 2, Issue:2 Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dopamine; Dose-Response Relationsh	1990
Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists. Journal of neural transmission. Parkinson's disease and dementia section, 1990, Volume: 2, Issue:2 Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dizocilpine Maleate; Fluphenazine;	1990
Inhibitory action of L-dopa. Neurology, 1989, Volume: 39, Issue:8 Topics: Animals; Humans; Levodopa; Mice; Parkinson Disease; Receptors, Dopamine; Receptors, Dopamine D2; Sul	1989
[Studies on the hypothalamic-pituitary dopaminergic system in Parkinson's disease and spinocerebellar degeneration. Response to TRH and sulpiride]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1987, Volume: 76, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Child; Dopamine; Female; Humans; Hypothalamo-Hypo	1987
[Parkinson's disease associated with trihexyphenidyl (THP) induced dysphonia plicae ventricularis]. Rinsho shinkeigaku = Clinical neurology, 1988, Volume: 28, Issue:4 Topics: Aged; Female; Humans; Movement Disorders; Parkinson Disease; Sulpiride; Tongue Diseases; Trihexyphen	1988
Quinpirole hydrochloride, a potential anti-parkinsonism drug. Neuropharmacology, 1987, Volume: 26, Issue:8 Topics: Animals; Benzazepines; Corpus Striatum; Dogs; Dose-Response Relationship, Drug; Ergolines; Grooming;	1987

Article

Year

Synergistic effect between quinpirole and L-NAME as well as sulpiride and L-arginine on the modulation of anxiety and memory processes in the 6-OHDA mouse model of Parkinson's disease: An isobologram analysis.

Neurobiology of learning and memory, 2021, Volume: 186

Topics: Adrenergic Agents; Animals; Anxiety; Arginine; Disease Models, Animal; Dopamine Agonists; Dopamine A

2021

Acute dopamine receptor blockade in substantia nigra pars reticulata: a possible model for drug-induced Parkinsonism.

Journal of neurophysiology, 2018, 12-01, Volume: 120, Issue:6

Topics: Action Potentials; Animals; Benzazepines; Disease Models, Animal; Dopamine Antagonists; Dopaminergic

2018

An octogenarian with Parkinson's disease psychosis that has responded favourably to low-dose sulpiride with facilitated motoric agility.

Asian journal of psychiatry, 2019, Volume: 43

Topics: Aged, 80 and over; Antipsychotic Agents; Humans; Male; Parkinson Disease; Psychotic Disorders; Sulpi

2019

Genotoxicity of the neurotransmitter dopamine in vitro.

Toxicology in vitro : an international journal published in association with BIBRA, 2009, Volume: 23, Issue:4

Topics: Animals; Antioxidants; Apoptosis; Cells, Cultured; Dopamine; Humans; Micronucleus Tests; Mutagenicit

2009

Levosulpiride-induced movement disorders.

Movement disorders : official journal of the Movement Disorder Society, 2009, Nov-15, Volume: 24, Issue:15

Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Brain; Female; Humans; Magnetic Resonance Imag

2009

[Parkinsonism induced by sulpiride and veralipride: two different stories].

Medicina clinica, 2011, Oct-15, Volume: 137, Issue:10

Topics: Adult; Aged; Brain Damage, Chronic; Contraindications; Dyskinesia, Drug-Induced; Europe; Female; Hum

2011

Lesioning the thalamus for dyskinesia.

Stereotactic and functional neurosurgery, 2001, Volume: 77, Issue:1-4

Topics: Antiparkinson Agents; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dyskinesias; Electrocoagulatio

2001

D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.

The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005, Feb-23, Volume: 25, Issue:8

Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Antipsych

2005

[Extrapyramidal adverse effects of veralipride (Agreal), a drug used to treat hot flushes: a propos of 17 cases].

La Revue de medecine interne, 2005, Volume: 26, Issue:6

Topics: Aged; Akathisia, Drug-Induced; Basal Ganglia Diseases; Dopamine Antagonists; Female; Humans; Male; M

2005

Central acute D2 stimulation worsens bladder function in patients with mild Parkinson's disease.

The Journal of urology, 2006, Volume: 175, Issue:1

Topics: Domperidone; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Severity of

2006

Increasing doses of l-sulpiride reveal dose- and spatial frequency-dependent effects of D2 selective blockade in the human electroretinogram.

Vision research, 1995, Volume: 35, Issue:18

Topics: Adult; Dose-Response Relationship, Drug; Electroretinography; Female; Humans; Male; Parkinson Diseas

1995

1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol inhibits tyrosine hydroxylase activity in rat striatal synaptosomes.

Journal of neural transmission. General section, 1994, Volume: 96, Issue:1

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biopterins; Chromatography, High Pressure Liq

1994

[Diagnosis and treatment of Parkinson's disease in the elderly].

Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1993, Volume: 30, Issue:12

Topics: Aged; Brain; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sulpirid

1993

The visual system in Parkinson's disease.

Advances in neurology, 1993, Volume: 60

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Contrast Sensitivity; Dopamine; Electroenceph

1993

Levodopa biotransformation in hemi-Parkinson rats: effect of dopamine receptor agonists and antagonists.

European journal of pharmacology, 1996, Feb-05, Volume: 296, Issue:3

Topics: Animals; Antiparkinson Agents; Benzazepines; Biotransformation; Corpus Striatum; Denervation; Dopami

1996

A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's disease pattern electroretinogram alterations.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 1999, Volume: 110, Issue:1

Topics: Adult; Brain; Electroencephalography; Electroretinography; Haloperidol; Humans; Parkinson Disease; R

1999

Inhibition of catechol-O-methyltransferase (COMT) in the brain does not affect the action of dopamine and levodopa: an in vitro electrophysiological evidence from rat mesencephalic dopamine neurons.

Journal of neural transmission (Vienna, Austria : 1996), 1999, Volume: 106, Issue:11-12

Topics: Animals; Benzophenones; Catechol O-Methyltransferase Inhibitors; Cells, Cultured; Dopamine; Dopamine

1999

Worsening of Parkinsonism after the use of veralipride for treatment of menopause: case report.

Arquivos de neuro-psiquiatria, 2001, Volume: 59, Issue:1

Topics: Dopamine Antagonists; Female; Humans; Menopause; Middle Aged; Parkinson Disease; Parkinson Disease,

2001

Tiapride and sulpiride in Parkinson's disease.

Lancet (London, England), 1978, Dec-02, Volume: 2, Issue:8101

Topics: Benzamides; Drug Evaluation; Dyskinesia, Drug-Induced; Humans; Parkinson Disease; Sulpiride

1978

[Value of sulpiride and tiapride in geriatrics. Antagonism between Parkinson disease and chorea].

Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille, 1979, Nov-17, Volume: Suppl 1

Topics: Aged; Benzamides; Chorea; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Sulpiride;

1979

Therapeutical efficacy of a combination of apomorphine with sulpiride or metoclopramide in Parkinsonism.

Psychopharmacologia, 1976, May-28, Volume: 47, Issue:2

Topics: Adult; Apomorphine; Drug Therapy, Combination; Haloperidol; Humans; Male; Metoclopramide; Parkinson

1976

Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.

Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:2

Topics: Aged; Apomorphine; Chlorpromazine; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Dr

1992

An electrophysiological study of D2 dopaminergic actions in normal human retina: a tool in Parkinson's disease.

Neuroscience letters, 1992, Jun-08, Volume: 140, Issue:1

Topics: Adult; Dopamine D2 Receptor Antagonists; Humans; Parkinson Disease; Receptors, Dopamine D2; Referenc

1992

MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys.

Pharmacology, biochemistry, and behavior, 1991, Volume: 38, Issue:4

Topics: Animals; Apomorphine; Blinking; Chlorocebus aethiops; Dopamine Agents; Haloperidol; Male; MPTP Poiso

1991

Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents.

Journal of neural transmission. Parkinson's disease and dementia section, 1990, Volume: 2, Issue:2

Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dopamine; Dose-Response Relationsh

1990

Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists.

Journal of neural transmission. Parkinson's disease and dementia section, 1990, Volume: 2, Issue:2

Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dizocilpine Maleate; Fluphenazine;

1990

Inhibitory action of L-dopa.

Neurology, 1989, Volume: 39, Issue:8

Topics: Animals; Humans; Levodopa; Mice; Parkinson Disease; Receptors, Dopamine; Receptors, Dopamine D2; Sul

1989

[Studies on the hypothalamic-pituitary dopaminergic system in Parkinson's disease and spinocerebellar degeneration. Response to TRH and sulpiride].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1987, Volume: 76, Issue:1

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Child; Dopamine; Female; Humans; Hypothalamo-Hypo

1987

[Parkinson's disease associated with trihexyphenidyl (THP) induced dysphonia plicae ventricularis].

Rinsho shinkeigaku = Clinical neurology, 1988, Volume: 28, Issue:4

Topics: Aged; Female; Humans; Movement Disorders; Parkinson Disease; Sulpiride; Tongue Diseases; Trihexyphen

1988

Quinpirole hydrochloride, a potential anti-parkinsonism drug.

Neuropharmacology, 1987, Volume: 26, Issue:8

Topics: Animals; Benzazepines; Corpus Striatum; Dogs; Dose-Response Relationship, Drug; Ergolines; Grooming;

1987